City

Perth (1)

Condition

Central Sympathetic Nervous System Diseases (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

Royal Perth Hospital (1)

Collaborator

Intervention

moxonidine 0.2 mg (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (1)

Study Type

Interventional (1)

central sympathetic nervous system diseases

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Central Sympathetic Nervous System Diseases Trial in Perth (Moxonidine 0.2 MG, )

Recruiting

Central Sympathetic Nervous System Diseases

Moxonidine 0.2 MG
placebo

Perth, Australia

Dobney Hypertension Centre

Oct 6, 2020